In fact, while they did not differ in reproductive hormonal and some metabolic parameters, the two groups showed considerable differences in insulin and HDL plasma levels as well as HOMA index (Table 2)
To view or add a comment, sign in The next GLP-1 race is not only which molecule performs better. It is also becoming a formulation race: oral small molecules peptide injectables multi-agonist receptor profiles adherence and real-world protocol constraints Lillys ACHIEVE-3 data put this shift into focus
When to consider dose reduction In some cases, stepping back down to a previous dose is the right move
They are naturally present in our environment, but their accumulation in the body can have harmful effects on health
The authors extend their sincere appreciation to the dedicated staff at the Health Data Science Center of Chung Shan Medical University Hospital for their invaluable assistance throughout this study
GLP1R agonists such as liraglutide and semaglutide are widely used to restore normal blood glucose levels in patients with type 2 diabetes (T2D) and to manage body weight in individuals with obesity